Loading data
SLGLNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 19.39 m USD | 11.54 m USD | 1.55 m USD | 3.88 m USD | 31.27 m USD |
| Research and development expense | 22.8 m USD | 17.8 m USD | 23.54 m USD | 12.68 m USD | 20.38 m USD |
| Operating profit | -7.54 m USD | -12.01 m USD | -29.31 m USD | -16.24 m USD | 2.96 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | — | — |
| Net income (reported basis) | -6.13 m USD | -10.58 m USD | -27.24 m USD | -14.92 m USD | 3.22 m USD |
| Basic earnings per share | -2.19 USD/share | -3.79 USD/share | -10.01 USD/share | -0.65 USD/share | 0.14 USD/share |
| Diluted earnings per share | -2.19 USD/share | -3.79 USD/share | -10.01 USD/share | -0.65 USD/share | 0.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.